CN108157939A - A kind of food with hypoglycemic effect and preparation method thereof - Google Patents
A kind of food with hypoglycemic effect and preparation method thereof Download PDFInfo
- Publication number
- CN108157939A CN108157939A CN201711169288.5A CN201711169288A CN108157939A CN 108157939 A CN108157939 A CN 108157939A CN 201711169288 A CN201711169288 A CN 201711169288A CN 108157939 A CN108157939 A CN 108157939A
- Authority
- CN
- China
- Prior art keywords
- food
- hypoglycemic effect
- parts
- ganoderma lucidum
- ginkgo biloba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 66
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 27
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 27
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 22
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 22
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 21
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 21
- 241000195493 Cryptophyta Species 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 239000012530 fluid Substances 0.000 claims abstract description 14
- 239000008103 glucose Substances 0.000 claims description 20
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 19
- 238000000855 fermentation Methods 0.000 claims description 16
- 230000004151 fermentation Effects 0.000 claims description 16
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 12
- 229910052711 selenium Inorganic materials 0.000 claims description 12
- 239000011669 selenium Substances 0.000 claims description 12
- 240000008042 Zea mays Species 0.000 claims description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 10
- 235000005822 corn Nutrition 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 9
- 230000000996 additive effect Effects 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000001963 growth medium Substances 0.000 claims description 8
- 238000012859 sterile filling Methods 0.000 claims description 6
- 239000007836 KH2PO4 Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 238000007792 addition Methods 0.000 claims description 3
- 241000222336 Ganoderma Species 0.000 claims description 2
- 229910052564 epsomite Inorganic materials 0.000 claims description 2
- 229930003944 flavone Natural products 0.000 claims description 2
- 150000002213 flavones Chemical class 0.000 claims description 2
- 235000011949 flavones Nutrition 0.000 claims description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 2
- 238000009423 ventilation Methods 0.000 claims description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 35
- 230000036039 immunity Effects 0.000 abstract description 14
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 9
- 208000002249 Diabetes Complications Diseases 0.000 abstract description 6
- 206010012655 Diabetic complications Diseases 0.000 abstract description 5
- 238000005520 cutting process Methods 0.000 abstract description 5
- 230000000116 mitigating effect Effects 0.000 abstract description 5
- 206010029164 Nephrotic syndrome Diseases 0.000 abstract description 4
- 206010062237 Renal impairment Diseases 0.000 abstract description 4
- 201000001421 hyperglycemia Diseases 0.000 abstract description 4
- 208000009928 nephrosis Diseases 0.000 abstract description 4
- 231100001027 nephrosis Toxicity 0.000 abstract description 4
- 208000016261 weight loss Diseases 0.000 abstract description 4
- 230000004580 weight loss Effects 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- 210000001541 thymus gland Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 241001474374 Blennius Species 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002865 immune cell Anatomy 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000004638 Dendrobium nobile Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010061481 Renal injury Diseases 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000007501 Thymosin Human genes 0.000 description 1
- 108010046075 Thymosin Proteins 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- -1 by join palpus Substances 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/60—Edible seaweed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of food with hypoglycemic effect and preparation method thereof, the food for having hypoglycemic effect includes following components according to weight percentage：70 95 parts of ganoderma lucidum fermented liquid, 5 10 parts of marine algae extract, 15 parts of moringa oleifera leaf extractive, 0.5 3 parts of ginkgo biloba p.e.The food with hypoglycemic effect of the present invention is Sugarless type fluid product, without peculiar smell, using the mutual coordinated of ganoderma lucidum fermented liquid, marine algae extract, moringa oleifera leaf extractive and ginkgo biloba p.e, plays the role for the treatment of diabetes.Have effects that following：（1）There is good mitigation, and effect can still continue after cutting out to the diabetic hyperglycemia shape as caused by alloxan；（2）The typical diabetes of diuresis, weight loss and renal impairment etc. caused by alleviating diabetes and diabetogenous nephrosis disease symptoms；（3）Body immunity is improved, reduces the generation of diabetic complication.
Description
Technical field
The present invention relates to technical field of functional food, relate in particular to a kind of food and its system with hypoglycemic effect
Preparation Method.
Background technology
Diabetes are a kind of endocrine and metabolic disorders diseases, main reasons is that insulin generates and the abnormal phase of effect
It closes.At present, the diabetes B that the whole world has diagnosed is up to l.3 hundred million people, and China is more than 40,000,000 people, and incidence is on gradually
It rises.Due to the frequently-occurring and seriousness of complication, oneself becomes after cardiovascular and cerebrovascular disease, tumour diabetes in the world
The third-largest chronic disease of human health is seriously endangered, has become the fifth-largest fatal disease in the whole world.
A kind of blood-sugar lowering tcm drug formula and preparation method thereof disclosed in existing number of patent application CN200510118948.8, in this
A kind of blood-sugar lowering tcm drug is disclosed in medicine composition, by join palpus, Radix Astragali, PORIA from Yunnan of China, rhizoma anemarrhenae, Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, the radix paeoniae rubrathe, rhizoma alismatis,
Malt, root of Chinese trichosanthes, glutinous rehmannia, sealwort, Radix Ophiopogonis, radix polygonati officinalis, the stem of noble dendrobium, dark plum, pueraria lobata, Cortex Eucommiae, Chinese yam rhizome, Fructus Corni, Gorgon fruit, sweet Chinese holly
Qi, Schisandra chinensis, pig pancreas, balsam pear are formed, which can be used in treating diabetes, but selected portion raw material is not food
Product, the party can only use as drug, be unable to reach the long-term harmless edible effect of diabetes patient, in addition in the formula ingredient compared with
It is more, and preparation method is complex, and production cost is higher.For this purpose, it is long-term harmless edible and can be badly in need of developing a kind of convenience
For treating the composition of diabetes, the immunity for improving Susceptible population.
Invention content
The purpose of the present invention is to provide a kind of food with hypoglycemic effect and preparation method thereof, to solve existing control
It is not notable to treat therapeutic effect existing for the drug of diabetes, and diabetic's complication height can not be alleviated, hypoimmunity
Defect.
For this purpose, the present invention provides a kind of food with hypoglycemic effect, include according to weight percentage with the following group
Point：70-95 parts of ganoderma lucidum fermented liquid, 5-10 parts of marine algae extract, 1-5 parts of moringa oleifera leaf extractive, 0.5-3 parts of ginkgo biloba p.e.
The present invention also provides a kind of preparation methods of the food with hypoglycemic effect, and the method includes following steps
Suddenly：
(1) ganoderma lucidum mycelium seed liquor or ganoderma lucidum fruitbody seed liquor are inoculated in addition selenium-rich corn powder, seaweed is extracted
Fermented and cultured is carried out in the culture medium of object and additive, obtains zymotic fluid；(2) leaf of Moringa is added in zymotic fluid after fermentation
Extract and ginkgo biloba p.e simultaneously stir evenly, and carry out sterile filling after cooling, obtain the food with hypoglycemic effect.
Compared with prior art, the advantages and positive effects of the present invention are：The present invention provides one kind to have hypoglycemic work
Food and preparation method thereof, the food with hypoglycemic effect of the invention are Sugarless type fluid product, without peculiar smell, profit
With the mutual coordinated of ganoderma lucidum fermented liquid, marine algae extract, moringa oleifera leaf extractive and ginkgo biloba p.e, treatment glycosuria is played
The effect of disease, dose is independent of blood sugar concentration, and patient need not test blood glucose, and healthy crowd is also to health care.The present invention
The food with hypoglycemic effect have it is following：(1) have to the diabetic hyperglycemia shape as caused by alloxan
Good mitigation, and effect can still continue after cutting out；(2) alleviate diabetes caused by diuresis, weight loss and
Typical case's diabetes such as renal impairment and diabetogenous nephrosis disease symptoms；(3) body immunity is improved, reduces the hair of diabetic complication
It is raw.
After the specific embodiment for reading the present invention, the other features and advantages of the invention will become clearer.
Specific embodiment
The specific embodiment of the present invention is described in detail below, it should be appreciated that described herein specific
Embodiment is merely to illustrate and explain the present invention, and is not intended to restrict the invention.
The health food of the present invention, component and parts by weight are：70-95 parts of ganoderma lucidum fermented liquid, 5-10 parts of marine algae extract,
1-5 parts of moringa oleifera leaf extractive, 0.5-3 parts of ginkgo biloba p.e.
Preferred component and parts by weight are：80-90 parts of ganoderma lucidum fermented liquid, 5-8 parts of marine algae extract, moringa oleifera leaf extractive
1.5-3 parts, 1-2 parts of ginkgo biloba p.e.
The ganoderma lucidum fermented liquid is that the glossy ganoderma mycelium fermentation liquid of addition selenium-rich corn culture or ganoderma lucidum are real in culture medium
Body zymotic fluid contains selenium element after fermentation in zymotic fluid, can play the role of protection and restore islet function, be conducive to improve
The symptom of diabetes reduces glucose and hemoglobin level in urine.Selenium element is to form glutathione peroxidase
Active constituent can prevent beta Cell of islet Oxidative demage, make its function normal, promote sugared part metabolism, reduce blood glucose and glucose in urine.
L-fucose content >=20% in marine algae extract, organic sulfate radical content >=15%, L-fucose and organic
Sulfate radical is the standard for assessing fucoidin content, and fucoidin can improve kidney vigor, avoid kidney failure, can also activated immune
Cell improves the immunity of the human body, and achievees the effect that tonify Qi of the kidney.
Polyoses content >=25% in moringa oleifera leaf extractive, polyoses content are the index for assessing moringa oleifera leaf extractive quality, are contained
Amount height illustrates extractive process purity height, wherein the other active components retained can also be concentrated.
Flavones content >=20% in ginkgo biloba p.e, GINKGO BILOBA EXTRACT can increase cerebrovascular blood flow, and expansion is coronal
Artery, heart and brain complication caused by avoiding diabetes, while improve body immunity.
The additions such as the potassium, manganese, chromium and the arginine that are rich in moringa oleifera leaf extractive, lysine, leucine, phenylalanine
Agent can contribute to excreting insulin and adjust blood glucose, effective against oxidation, antagonism certainly with activating immune cell, strengthen immunity
By base, controllable symptom alleviates the state of an illness or even breaks away from the puzzlement of diabetes.
Marine algae extract avoids kidney injury, alleviates diabetic symptom indirectly, by seaweed before fermentation by enhancing kidney function
Extract adds in, and by the fermentation of ganoderma lucidum thalline, decomposes macromolecular substances in marine algae extract, is more easy to the utilization that is absorbed by the body.
Ginkgo biloba p.e and ganoderma lucidum polysaccharide can improve immunity, protect cardiovascular and cerebrovascular, prevent diabetic complication
Occur.
The present invention combines the traditional Chinese medical science for diabetes " diabetes ", " deficiency of kidney-QI ", " scorching cohesion ", the disease of " functional activities of the body fluid consumption wound "
Cause, provides a kind of food with hypoglycemic effect, and the food with hypoglycemic effect of the invention is produced for Sugarless type liquid
Product without peculiar smell, are matched using the mutual collaboration of ganoderma lucidum fermented liquid, marine algae extract, moringa oleifera leaf extractive and ginkgo biloba p.e
It closes, plays the role for the treatment of diabetes.The food with hypoglycemic effect of the present invention has following：(1) to by four oxygen
Diabetic hyperglycemia shape caused by pyrimidine has good mitigation, and effect can still continue after cutting out；(2) delay
The typical diabetes of diuresis, weight loss and renal impairment etc. caused by solving diabetes and diabetogenous nephrosis disease symptoms；(3) body is improved
Body immunity reduces the generation of diabetic complication.
The preparation method of the food with hypoglycemic effect of the present invention includes the following steps：
(1) ganoderma lucidum mycelium seed liquor or ganoderma lucidum fruitbody seed liquor are inoculated in addition selenium-rich corn powder, seaweed is extracted
Fermented and cultured is carried out in the culture medium of object and additive, obtains zymotic fluid；
(2) moringa oleifera leaf extractive and ginkgo biloba p.e are added in zymotic fluid after fermentation and is stirred evenly, is treated cold
But sterile filling is carried out afterwards, obtains the food with hypoglycemic effect.
In step (1), the additive amount of selenium-rich corn powder is 16-25g/L, and additive includes glucose, KH2PO4、
MgSO4·7H2O, additive amount are respectively 16-25g/L, 0.5-1.5g/L, 0.5-1.5g/L.
In step (1), cultivation temperature is 28 DEG C, mixing speed 200r/min, ventilation speed 3L/min, fermentation time
For 110h.
It states in step (2), whipping temp is 121 DEG C, and stirring pressure is 105kpa, mixing time 15min.
With reference to specific embodiment and function test, the present invention is further illustrated, the ratio that the present invention is previously mentioned
Example, " part " if without particularly marking, are subject to weight.
Embodiment 1
The food with hypoglycemic effect of the present embodiment is made of the raw material of following weight proportion：Ganoderma lucidum fermented liquid 75
5 parts of part, 15 parts of marine algae extract, 5 parts of moringa oleifera leaf extractive and ginkgo biloba p.e.
Preparation method includes the following steps：(1) ganoderma lucidum thalline seed liquor is inoculated in addition marine algae extract, 20g/L richnesses
Selenium corn flour, 20g/L glucose, 1g/L KH2PO4With 1g/L MgSO4·7H2Fermented and cultured is carried out in the culture medium of O；Culture
28 DEG C, mixing speed 200r/min of temperature, divulge information 3L/min, fermentation time 110h.(2) add in zymotic fluid after fermentation
Add moringa oleifera leaf extractive and ginkgo biloba p.e and stir evenly, carry out sterile filling after cooling, obtain that there is hypoglycemic work
Food；Whipping temp is 121 DEG C, and stirring pressure is 105kpa, mixing time 15min.
Embodiment 2
The food with hypoglycemic effect of the present embodiment is made of the raw material of following weight proportion：Ganoderma lucidum fermented liquid 70
5 parts of part, 15 parts of marine algae extract, 10 parts of moringa oleifera leaf extractive and ginkgo biloba p.e.
Preparation method includes the following steps：(1) ganoderma lucidum thalline seed liquor is inoculated in addition marine algae extract, 20g/L richnesses
Selenium corn flour, 20g/L glucose, 1g/L KH2PO4With 1g/L MgSO4·7H2Fermented and cultured is carried out in the culture medium of O；Culture
28 DEG C, mixing speed 200r/min of temperature, divulge information 3L/min, fermentation time 110h.(2) add in zymotic fluid after fermentation
Add moringa oleifera leaf extractive and ginkgo biloba p.e and stir evenly, carry out sterile filling after cooling, obtain that there is hypoglycemic work
Food；Whipping temp is 121 DEG C, and stirring pressure is 105kpa, mixing time 15min.
Embodiment 3
The food with hypoglycemic effect of the present embodiment is made of the raw material of following weight proportion：Ganoderma lucidum fermented liquid 80
1 part of part, 12 parts of marine algae extract, 7 parts of moringa oleifera leaf extractive and ginkgo biloba p.e.
Preparation method includes the following steps：(1) ganoderma lucidum thalline seed liquor is inoculated in addition marine algae extract, 20g/L richnesses
Selenium corn flour, 20g/L glucose, 1g/L KH2PO4With 1g/L MgSO4·7H2Fermented and cultured is carried out in the culture medium of O；Culture
28 DEG C, mixing speed 200r/min of temperature, divulge information 3L/min, fermentation time 110h.(2) add in zymotic fluid after fermentation
Add moringa oleifera leaf extractive and ginkgo biloba p.e and stir evenly, carry out sterile filling after cooling, obtain that there is hypoglycemic work
Food；Whipping temp is 121 DEG C, and stirring pressure is 105kpa, mixing time 15min.
Contractile studies
1st, the hypoglycemic experiment of mouse
Diabetic mice is obtained using alloxan method is injected intraperitoneally, diabetic mice is divided into four groups, is eaten respectively
Animal feed, the food of embodiment 1, the food of embodiment 2 and embodiment 3 food.The mouse for not injecting alloxan is taken to make
For normal mouse, normal mouse is divided into four groups, respectively edible animal feed, the food of embodiment 1, embodiment 2 food and
The food of embodiment 3.To diabetic mice and normal mouse feeding 30 days, take a blood sample from mouse tail within every 5 days, it is glycoxidative with grape
Its fasting blood-glucose of enzymatic assays, test data are as shown in table 1.Animal feed refers to the mouse grain that can be bought on the market.
Table 1
As seen from the data in Table 1, for normally organizing mouse, edible animal feed, the food of embodiment 1, embodiment 2
The blood glucose of the mouse of food and the food of embodiment 3 is in more stable level, and illustrate the present invention has hypoglycemic work
Food will not have an impact the blood glucose of normal mouse.And for diabetes group mouse, edible animal feed it is small
The blood glucose of mouse is persistently increased with the growth of nursing time, eats food, the food of embodiment 2 and the food of embodiment 3 of embodiment 1
The blood glucose of the mouse of product is below the blood glucose of the mouse of the edible animal feed of same time period；And after 30 days stop feeding,
The blood glucose of the mouse of the food of the food of edible embodiment 1, the food of embodiment 2 and embodiment 3 does not have a rebound raising yet.
It is obtained by analyzing above, the food with hypoglycemic effect of the invention is high to the diabetes as caused by alloxan
Blood glucose symptom has good mitigation, and effect can still continue after cutting out；In addition normal mouse takes the present invention
Food with hypoglycemic effect after, there is not abnormal phenomenon in blood glucose value, and illustrate the present invention has hypoglycemic effect
Food will not have an adverse effect to the blood glucose of normal mouse while effective control of hyperglycemia.
2nd, to the influence of mouse immune organ
Thymus gland and spleen are important immune organ, and organ index can reflect body's immunity to a certain extent
It is strong and weak.The major function of thymus gland is to generate T lymphocytes and secretion thymosin extrasin, is primarily involved in cellular immunity；Have in spleen abundant
Lymphocyte and macrophage, but bone-marrow-derived lymphocyte large percentage, therefore more close with humoral immunity relationship.Thymus gland and spleen
Dirty weight is related to the immunity of body, and the weight of thymus gland and spleen is bigger, and immunity of organisms is relatively better.To feeding 36 days
Normal mouse and diabetic mice test weight, thymic weight and spleen weight, test data later is as shown in table 2.
Table 2
As seen from the data in Table 2, it is grown by the feeding of 36 days, for normally organizing mouse, with edible animal feed
Mouse is compared, and eats the food, the food of embodiment 2 and the thymus gland of mouse of food and the ratio of weight of embodiment 3 of embodiment 1
Example and the ratio of spleen and weight are promoted, and illustrate the food with hypoglycemic effect of the present invention for normal mouse
Immunity plays the role of a degree of raising.For diabetic mice, compared with the mouse of edible animal feed, eat
The thymus gland of mouse and the ratio of weight and spleen and body of the food of the food of embodiment 1, the food of embodiment 2 and embodiment 3
The ratio of weight is promoted, and illustrates that the food with hypoglycemic effect of the present invention plays the immunity of diabetic mice
Significant restitution.
It is obtained by analyzing above, the food with hypoglycemic effect of the invention can effectively restore exempting from for diabetes group mouse
Epidemic disease function, and also have enhancing effect to the immune function of normal mouse, belong to safe and non-toxic food.
3rd, conclusion
The food with hypoglycemic effect of the present invention has following：(1) to the diabetes as caused by alloxan
Hyperglycemic symptoms have good mitigation, and effect can still continue after cutting out；(2) it is more caused by alleviation diabetes
The typical diabetes such as urine, weight loss and renal impairment and diabetogenous nephrosis disease symptoms；(3) body immunity is improved, reduces sugar
The generation of the sick complication of urine.
The above embodiments are merely illustrative of the technical solutions of the present invention rather than is limited；Although with reference to aforementioned reality
Example is applied the present invention is described in detail, it for those of ordinary skill in the art, still can be to aforementioned implementation
Technical solution recorded in example modifies or carries out equivalent replacement to which part technical characteristic；And these are changed or replace
It changes, the spirit and scope for claimed technical solution of the invention that it does not separate the essence of the corresponding technical solution.
Claims (10)
1. a kind of food with hypoglycemic effect, which is characterized in that
Include following components according to weight percentage：
70-95 parts of ganoderma lucidum fermented liquid, 5-10 parts of marine algae extract, 1-5 parts of moringa oleifera leaf extractive, ginkgo biloba p.e 0.5-
3 parts.
2. there is the food of hypoglycemic effect as described in claim 1, which is characterized in that
Include following components according to weight percentage：
80-90 parts of ganoderma lucidum fermented liquid, 5-8 parts of marine algae extract, 1.5-3 parts of moringa oleifera leaf extractive, ginkgo biloba p.e 1-2
Part.
3. the food according to claim 1 or 2 with hypoglycemic effect, which is characterized in that
The ganoderma lucidum fermented liquid is the glossy ganoderma mycelium fermentation liquid of addition selenium-rich corn culture or ganoderma lucidum fruitbody hair in culture medium
Zymotic fluid.
4. the food according to claim 1 or 2 with hypoglycemic effect, which is characterized in that
L-FUC content >=20% in the marine algae extract, organic sulfate radical content >=15%.
5. the food according to claim 1 or 2 with hypoglycemic effect, which is characterized in that
Polyoses content >=25% in the moringa oleifera leaf extractive.
6. the food according to claim 1 or 2 with hypoglycemic effect, which is characterized in that
Flavones content >=20% in the ginkgo biloba p.e.
A kind of 7. preparation method of food with hypoglycemic effect according to claim 1 or 2, which is characterized in that institute
The method of stating includes the following steps：
（1）By ganoderma lucidum mycelium seed liquor or ganoderma lucidum fruitbody seed liquor be inoculated in addition selenium-rich corn powder, marine algae extract and
Fermented and cultured is carried out in the culture medium of additive, obtains zymotic fluid；
（2）Moringa oleifera leaf extractive and ginkgo biloba p.e are added in zymotic fluid after fermentation and is stirred evenly, after cooling
Sterile filling is carried out, obtains the food with hypoglycemic effect.
8. the preparation method of the food according to claim 7 with hypoglycemic effect, which is characterized in that
The step（1）In, the additive amount of the selenium-rich corn powder is 16-25 g/L, and the additive includes glucose
KH2PO4、MgSO4·7H2O, additive amount are respectively 16-25g/L, 0.5-1.5 g/L, 0.5-1.5 g/L.
9. the preparation method of the food according to claim 7 with hypoglycemic effect, which is characterized in that
The step（1）In, cultivation temperature is 28 DEG C, mixing speed 200r/min, ventilation speed 3L/min, fermentation time
For 110h.
10. the preparation method of the food according to claim 7 with hypoglycemic effect, which is characterized in that
The step（2）In, whipping temp is 121 DEG C, and stirring pressure is 105kpa, mixing time 15min.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711169288.5A CN108157939A (en) | 2017-11-13 | 2017-11-13 | A kind of food with hypoglycemic effect and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711169288.5A CN108157939A (en) | 2017-11-13 | 2017-11-13 | A kind of food with hypoglycemic effect and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108157939A true CN108157939A (en) | 2018-06-15 |
Family
ID=62527186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711169288.5A Pending CN108157939A (en) | 2017-11-13 | 2017-11-13 | A kind of food with hypoglycemic effect and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108157939A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102084859B1 (en) * | 2018-10-16 | 2020-03-04 | 사단법인 한국불교 바로알기 | Fermented moringa and Curcuma aromatica tea and preparation method thereof |
| NL2030836B1 (en) * | 2022-02-07 | 2023-08-14 | Jingzhiyuan Ganoderma Lucidum Planting Cooperative In Hengshui Dev Zone | Ganoderma lucidum fermentative liquid food and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101423855A (en) * | 2008-10-28 | 2009-05-06 | 山东好当家海洋发展股份有限公司 | Method for preparing polysaccharide by using lucidum strain fermented laminaria leftover |
| CN101703533A (en) * | 2009-09-29 | 2010-05-12 | 武征杰 | Ginkgo ganoderma lucidum spore capsule and preparation method thereof |
| CN102533901A (en) * | 2010-12-30 | 2012-07-04 | 李德远 | Preparation method of selenium-enriched ganoderma lucidum polysaccharide |
| CN106072088A (en) * | 2016-06-28 | 2016-11-09 | 黄秀英 | Thallus Laminariae (Thallus Eckloniae) Ganoderma mycelium is prepared for culture medium with Thallus Laminariae (Thallus Eckloniae) |
| CN106109552A (en) * | 2016-06-27 | 2016-11-16 | 靖西市秀美边城农业科技有限公司 | Moringa compound liquid preparation of prevention and treatment cardiovascular and cerebrovascular vessel and preparation method thereof |
-
2017
- 2017-11-13 CN CN201711169288.5A patent/CN108157939A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101423855A (en) * | 2008-10-28 | 2009-05-06 | 山东好当家海洋发展股份有限公司 | Method for preparing polysaccharide by using lucidum strain fermented laminaria leftover |
| CN101703533A (en) * | 2009-09-29 | 2010-05-12 | 武征杰 | Ginkgo ganoderma lucidum spore capsule and preparation method thereof |
| CN102533901A (en) * | 2010-12-30 | 2012-07-04 | 李德远 | Preparation method of selenium-enriched ganoderma lucidum polysaccharide |
| CN106109552A (en) * | 2016-06-27 | 2016-11-16 | 靖西市秀美边城农业科技有限公司 | Moringa compound liquid preparation of prevention and treatment cardiovascular and cerebrovascular vessel and preparation method thereof |
| CN106072088A (en) * | 2016-06-28 | 2016-11-09 | 黄秀英 | Thallus Laminariae (Thallus Eckloniae) Ganoderma mycelium is prepared for culture medium with Thallus Laminariae (Thallus Eckloniae) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102084859B1 (en) * | 2018-10-16 | 2020-03-04 | 사단법인 한국불교 바로알기 | Fermented moringa and Curcuma aromatica tea and preparation method thereof |
| NL2030836B1 (en) * | 2022-02-07 | 2023-08-14 | Jingzhiyuan Ganoderma Lucidum Planting Cooperative In Hengshui Dev Zone | Ganoderma lucidum fermentative liquid food and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103504305B (en) | Health product with blood sugar reduction function and preparation method thereof | |
| CN102526479B (en) | Health-care medicine formula with functions of enhancing immunity and lowering blood sugar | |
| CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
| CN104082672B (en) | A kind of health-preserving porridge with effect of lowering blood sugar and preparation method thereof | |
| CN102021101B (en) | Preparation method of healthy wine for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN105053641A (en) | Sorghum type meat duckling feed and preparation method thereof | |
| CN108157939A (en) | A kind of food with hypoglycemic effect and preparation method thereof | |
| CN106235318A (en) | The method preparing ferment for primary raw material with Flos Lonicerae, Rhizoma Curcumae Longae | |
| CN104543767A (en) | Blood glucose-reduction dieto-therapeutic noodle and preparation method thereof | |
| CN105077467A (en) | Health-care abalone-sea cucumber beverage with blood sugar-reducing function | |
| CN104893935A (en) | Abalone and sea cucumber compound wine with effect of delaying senescence | |
| KR101935848B1 (en) | Food composition for improving hyperglycemia using Brassica rapa | |
| CN108497169A (en) | A kind of livestock and poultry Chinese herb feed additive and preparation method thereof | |
| CN108094629A (en) | A kind of glutinous rehmannia leaf tea and preparation method | |
| CN107047852A (en) | Preparation method of multifunctional burdock health-care tea pulp | |
| CN106692760A (en) | Golden flower wine formula for preventing diabetes and preparation method thereof | |
| CN105838538A (en) | Formula and preparation method of dark tea golden camellia health care wine | |
| CN108070503A (en) | A kind of sealwort mulberry health-care wine and its production method | |
| CN104946491A (en) | Abalone-holothurian compound wine with blood sugar reducing function | |
| CN104921125A (en) | Dried scallop and trepang compound liquid having blood glucose reducing function | |
| CN108013238A (en) | Disease-resistant Chinese herbal medicine extract of lamb materials and preparation method thereof | |
| CN1561767A (en) | Sugar reducing yoghurt | |
| CN104893927A (en) | Abalone compound-prepared wine with hyperglycemia lowering effect | |
| CN105029609A (en) | Abalone and dried scallop health beverage with blood sugar lowering efficacy | |
| CN106578916A (en) | Production method of mulberry and bombyx mori noodles and production method of byproduct namely mulberry wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20190306 Address after: 266000 Mingyue Road 777, Huangdao District, Qingdao City, Shandong Province Applicant after: Qingdao Bright Moon Seaweed Group Co., Ltd. Address before: 266000 Mingyue Road 777, Huangdao District, Qingdao City, Shandong Province Applicant before: Qingdao Qing Jie Biological Technology Co., Ltd. |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180615 |